ScinnoHub Pharmaceutical Co., Ltd.
6 clinical trials · Sponsor
◉ Watch ScinnoHub Pharmaceutical Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| Study of SNH-118110 in Advanced Solid Tumors (NCT07649200) | ScinnoHub Pharmaceutical Co., Ltd. | 2026-06-26 |
| A Study of SNH-119014 in Adult Participants With Non-transfusion-dependent Thalassemia (NTDT) (NCT07579949) | ScinnoHub Pharmaceutical Co., Ltd. | 2026-06-18 |
| Study on BT-114143 Reducing Perioperative Bleeding in Total Knee Arthroplasty（TKA） (NCT07127042) | ScinnoHub Pharmaceutical Co., Ltd. | 2025-08-27 |
| A Phase I Study of SNH-119014 in Healthy Volunteers (NCT07087262) | ScinnoHub Pharmaceutical Co., Ltd. | 2025-06-27 |
| Evaluation of Safety, Efficacy, and Pharmacokinetics of BT-114143 Injection in Patients With Abnormal Uterine Bleeding (NCT07169214) | ScinnoHub Pharmaceutical Co., Ltd. | 2024-10-30 |
| Evaluation of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of BT-114143 Injection in Healthy Subjects (NCT07169240) | ScinnoHub Pharmaceutical Co., Ltd. | 2023-02-06 |
Track ScinnoHub Pharmaceutical Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.